Skip to main navigation Skip to search Skip to main content

Neonatal Opioid Withdrawal Syndrome (NOWS) Knowledge Among Women in Treatment for Opioid Use Disorder

  • T. Almeida
  • , B. Thakkar
  • , T. Kimbrough
  • , C. E. Martin

Research output: Contribution to conferencePosterpeer-review

Abstract

Background: Opioid-related deaths are a leading cause of pregnancy-associated mortality, and the prevalence of NOWS is increasing. Caregiving environments can reduce or eliminate the need for pharmacologic treatment of NOWS. However, insufficient parenting knowledge likely interferes with its optimal implementation. The primary objective of this study was to assess misinformation related to the peripartum transition and NOWS among women in treatment for opioid use disorder (OUD).
Methods: This is a secondary data analysis from an ongoing study to develop and test a patient education tool. A novel NOWS knowledge survey was developed based on clinical experience and literature consisting of 12 true/false questions. Pregnant (3rd trimester) and postpartum (< 7 days since delivery) women on medication for OUD (N = 22) completed this one-time, anonymous survey in a specialized clinic providing integrated perinatal and OUD care.
Results: The proportion of correct responses varied widely across question domains. Almost all women correctly identified NOWS signs/symptoms and nonpharmacologic NOWS treatments (100% skin-to-skin, 95% rooming in) except for breastfeeding (76% correct). Only 67% correctly stated that not all infants exposed to medication for OUD would need pharmacologic NOWS treatment, and 71% state that the infant would likely be discharged after the mother. Lastly, only 59% of women correctly reported that child welfare “will do what is best for me and my baby,” and 77% reported that the postpartum period is high risk for compromised recovery.
Conclusion: Despite receiving counseling from both obstetrics and addiction medicine providers, women on medication for OUD continue to have high levels of misinformation regarding expectations for the peripartum transition and care of the infant at risk of NOWS. Educational interventions tailored for the mother-infant dyad affected by OUD that can be easily implemented into clinical care are urgently needed, and patient-reported data should guide their development.
Original languageEnglish
Pages14
Number of pages1
Publication statusPublished - 19 Jun 2020
Event12th International Women’s and Children’s Health and Gender Group VIRTUAL Conference - 2020 Virtual InWomens Conference
Duration: 19 Jun 202019 Jun 2020
Conference number: 12th
https://gendercenter.rti.org/12th-international-womens-and-childrens-health-and-gender-group-virtual-conference

Conference

Conference12th International Women’s and Children’s Health and Gender Group VIRTUAL Conference
Abbreviated title2020 Virtual InWomens Conference
Period19/06/2019/06/20
Internet address

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Health Disparities
  • Opiate Use
  • Pregnant and Parenting Women

Fingerprint

Dive into the research topics of 'Neonatal Opioid Withdrawal Syndrome (NOWS) Knowledge Among Women in Treatment for Opioid Use Disorder'. Together they form a unique fingerprint.

Cite this